Skip to content

Vital Farms stock

VITLNASDAQ

Vital Farms, Inc., Consumer DefensiveISIN US92847W1036

$8.97▼ $0.50 (−5.3%)Closing price of 12 Nov 2026

38Score 38 out of 100, Weak

Turn on early warning

Price and trend

41 / 100

Price history

−72% in one year

The chart shows daily closes over 6 years, adjusted for stock splits and without dividends. Click into the chart to set a price alert at that price.

Long-term trend

Below the 200-day line: the price is 32% below it.

Trend change

Since December 2025 the 50-day line has been below the 200-day line; the trend has turned down.

Momentum

Normal: the price is neither overheated nor sold off (RSI 48).

Distance to the high

The price is 74% below its 52-week high. Largest decline in 6 years: 84% (August 2025 to October 2026).

Chart figures for advanced users
SMA 50$9.61
Average price of the last 50 trading days, shows the short-term trend.
SMA 200$13.16
Average price of the last 200 trading days, shows the long-term trend.
RSI (14)48
Relative strength over the last 14 days on a scale from 0 to 100. Above 70 the price counts as overheated, below 30 as sharply fallen.
MACDabove the signal line
Compares a fast and a slow price average. Above its signal line momentum is rising, below it momentum is fading.
Support$8.16
The lowest closing price of the last twelve months.
Resistance$34.53
The highest closing price of the last twelve months.
Market cap
$406.6M
Div. yield
no dividend
Loss
includes one-off items
Loss expected
Fair value
$4.96

Snapshot

Computed from the data by fixed rules, no AI

  • Vital Farms, Inc. belongs to the Agricultural Farm Products industry (United States) and, with a market value of $385.14M, is number 20 of 24 companies in its industry on MEQIRI.
  • In fiscal 2025 it reported revenue of $759.44M (up 25.3% year on year) and earnings of $66.28M (up 24.2%).
  • For fiscal 2026, analysts expect on average revenue of $729.42M (down 4%) and adjusted earnings per share of −$0.83.
Show more
  • MEQIRI Score 38 out of 100 (Weak): rank 285 of 295 in Consumer Defensive, median 62.
  • Our model puts fair value at $4.96, with the price 91% above it.

In plain words

The numbers on this page in plain words, written by an AI

Strengths

  • Earnings per share growingUp 36.9% a year since 2020.
  • Growing faster than its industryRevenue up 28.8% a year since 2020, Agricultural Farm Products median 11.6%.
  • High return on capitalReturn on invested capital 30.6% in fiscal 2025, Agricultural Farm Products median 4.6%.

Weaknesses

  • DilutionShare count up 56% since 2020.Capital allocation 20
  • Share price fell sharplyDown 73% over the last 12 months.Momentum 46
  • Loss-makingLoss of $22.72M over the last 12 months.Fundamentals 47
38/ 100
MEQIRI Score
Weak

The score is held back by capital allocation and profitability.

Daily figure as of 12 Nov 2026

How the score is calculated

Score overview

Score since yesterday from 40 to 38.

Fundamental quality fluctuates.

Profit consistency89% of years
Cash conversion (free cash flow to earnings, 12 months)not measured
ROIC (12 months)−7.0%
Positive free cash flow56% of years
How this category is measured

Score history

The full history of up to 20 years comes with MEQIRI Pro.

See plans

Crash risk high

How well MEQIRI warns

One of the 30% with the highest crash risk among smaller stocks.

From 2016 to 2025, 36 in 100 such stocks fell 30% or more within a year, against a group average of 23 in 100.

What drives the risk

  • price far below its 52-week high
  • high price swings
  • weak fundamentals

What lowers it

  • price not overheated over the past year

Valuation

Valuation signal

Modestly overvalued
Price
$9.47
Fair value
$4.96
Gap to fair value
+91%

Closing price of 11 Nov 2026, used by the daily score.

In our model the price counts as cheap below $3.31 and expensive above $9.92 (uncertainty very high, based on the price swings of the past year).

Calculated with a cost of equity of 8.8%. At 9.8% the fair value would be $3.80, at 7.8% it would be $6.72.

Valuation metrics

no data
329
Fair value (model)
$4.96

From the cash-flow model alone; without earnings there is no industry value.

Calculate with your own assumptions

Company performance

This shows several years of history with an automatic assessment.

Revenue

9 years

In the twelve months to 27 Sep 2026, revenue rose 5.2% on the twelve months before. Revenue has grown strongly since 2017, at around 34% per year.

Margins

9 years
  • Gross margin
  • Operating margin
  • Net margin

In fiscal 2025: gross 38%, operating 12%, net 9%. Last 12 months: net −3%.

Debt & balance sheet

latest quarter
0.67
> 100x
1.56
Cash & equivalents
$83.95M

The balance sheet is solid, with moderate debt and comfortable interest coverage.

Earnings

Next earnings
25 Feb 2027in 105 days
Last reported
3 Nov 2026EPS reported −$0.15 (expected −$0.11)below expectations

Analyst estimates

Analysts have cut their 2027 earnings estimate by 136.8% since 15 Oct 2026. Falling estimates often precede bad news.

Fiscal 20267 analysts
Earnings per share
−$0.83−56.8%
Revenue
$729.42M−4.8%
Fiscal 20277 analysts
Earnings per share
−$0.10−136.8%
Revenue
$766.05M−6.7%

MEQIRI has stored the estimates since 15 Oct 2026. Until 30 days are available, the card shows the change since that day. Mean estimate according to Financial Modeling Prep. No price target and no recommendation.

Company outlook confirmed

Share price after the results: 0.0%

2026 guidance reaffirmed: net revenue of $775 million to $800 million, adjusted EBITDA of $0 to $10 million.

Supporting passage from the call, verbatim
“Looking ahead to the rest of the year, we are reaffirming our previous guidance, which calls for net revenue of $775 million to $800 million and adjusted EBITDA of $0 to $10 million.”

The outlook is not part of the score and not a recommendation to buy or sell.

From the earnings call on 6 Aug 2026 (fiscal Q2 2026), read by AI.

Insiders

Open-market purchases and sales by executives, board members and major holders

All insider purchases
Cluster buy

11 insiders bought on the open market between 13 May 2026 and 19 May 2026, $421,992 in total. One insider sold, $674,648 in total.

Sales say less than purchases: many insiders sell on a fixed plan, for taxes or to diversify.

  • Ohayer MatthewSale

    9 Nov 2026, Major holder

    Shares
    66,200
    Price
    $9.68
    Value
    $640,816
  • Ohayer MatthewSale

    6 Nov 2026, Major holder

    Shares
    3,550
    Price
    $9.53
    Value
    $33,832
  • Van Hoven Reena ChauhanPurchase

    19 May 2026, Chief People Officer

    Shares
    2,242
    Price
    $8.92
    Value
    $19,999
Show 10 more
  • Flanagan Glenda JPurchase

    18 May 2026, Board

    Shares
    6,100
    Price
    $8.33
    Value
    $50,813
  • Coon StephaniePurchase

    15 May 2026, Chief Strategy Officer

    Shares
    5,895
    Price
    $8.42
    Value
    $49,636
  • Amoo-Gottfried Kofi OwusuPurchase

    15 May 2026, Board

    Shares
    2,375
    Price
    $8.45
    Value
    $20,069
  • Kennedy Kelly J.Purchase

    14 May 2026, Board

    Shares
    2,500
    Price
    $8.40
    Value
    $21,000
  • McKeon KathrynPurchase

    14 May 2026, CMO and GM, Butter

    Shares
    604
    Price
    $8.28
    Value
    $5,001
  • Cyr William B.Purchase

    14 May 2026, Board

    Shares
    6,000
    Price
    $8.52
    Value
    $51,120
  • Pappas Peter NicholasPurchase

    14 May 2026, CSO and President, Eggs

    Shares
    3,500
    Price
    $8.51
    Value
    $29,785
  • Holland Joseph MichaelPurchase

    14 May 2026, Chief Supply Chain Officer

    Shares
    12,484
    Price
    $8.00
    Value
    $99,872
  • Ruiz GiselPurchase

    13 May 2026, Board

    Shares
    6,151
    Price
    $8.13
    Value
    $50,008
  • Post Denny MariePurchase

    13 May 2026, Board

    Shares
    3,000
    Price
    $8.23
    Value
    $24,690

Source: Form 4 filings with the US Securities and Exchange Commission. Grants, option exercises, gifts and tax withholdings are hidden. Not a recommendation to buy.

Sector comparison

295 rated companies in Consumer Defensive

Rank 285 of 295
285/ 295
This company
38
Sector median
62

Categories against the sector median

ProfitabilityMedian of 295 companies16 (median 54)38 below the median
GrowthMedian of 295 companies43 (median 50)7 below the median
FundamentalsMedian of 295 companies47 (median 79)32 below the median
ValuationMedian of 290 companies with a value25 (median 65)40 below the median
StabilityMedian of 295 companies68 (median 68)0 at the median
Capital allocationMedian of 295 companies20 (median 62)42 below the median
Technical analysisMedian of 295 companies41 (median 65)24 below the median
MomentumMedian of 295 companies46 (median 60)14 below the median

The median is the middle value: half of the companies in the sector lie above it, half below. Categories with too few comparable companies are left out.

Competitors in Agricultural Farm Products

The next larger and next smaller companies by market value

All 24 Agricultural Farm Products stocks

ETFs that hold Vital Farms

Held by 9 ETFs on Xetra. Shown per index: the ETF with the largest weight.

Show 5 more

Holdings as reported by the funds via FMP, excluding swap ETFs (their holdings are only collateral).

Data status and sources

Score
Daily value of 12 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 28 Dec 2025
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 7 Aug 2026)
  • Valuation signal Fairly valued since 12 Nov 2026, previously Overvalued
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy